Skip to main content
Clinical Trials/NCT01861028
NCT01861028
Terminated
Not Applicable

Study Comparing Fit of the iTotal Versus Standard Total Knee Implants

Restor3D1 site in 1 country44 target enrollmentStarted: February 2013Last updated:
ConditionsOsteoarthritis

Overview

Phase
Not Applicable
Status
Terminated
Sponsor
Restor3D
Enrollment
44
Locations
1
Primary Endpoint
Phase II: Number of Participants With an Off-the-Shelf Implant Displaying an Overhang of 3 mm or Greater

Overview

Brief Summary

This study compares intraoperative fit of the patient-specific iTotal knee replacement to other standard knee replacement implants

Detailed Description

The study is designed as a single center, two arm analysis. The study will be completed in two phases, based on measurement type.

All additional data will be obtained from pre and post-operative subject surveys, operative and discharge records and radiographs.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patients who are scheduled for a standard total knee replacement
  • Patient who are scheduled for patient-specific total knee replacement (iTotal)
  • Patient age \> 18 years

Exclusion Criteria

  • Patients who do not receive a total knee replacement
  • Unwilling or unable to comply with study requirements

Outcomes

Primary Outcomes

Phase II: Number of Participants With an Off-the-Shelf Implant Displaying an Overhang of 3 mm or Greater

Time Frame: Intraoperatively, up to 120 minutes

Fit will be measured in 3 quadrants on the tibia using a ruler to measure the distance between the off-the-shelf design and the edge of the tibia.

Phase I: Number of Participants With a Customized Tibia Implant Displaying an Overhang of 3 mm or Greater

Time Frame: Intraoperatively, up to 120 minutes

Fit will be measured in 4 quadrants on the tibia using a ruler to measure the distance between the customized implant and the edge of the tibia.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Restor3D
Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials